Shifting the goalposts in obesity drug development

by AiNewsBlog Jun, 24

written by AiNewsBlog Jun, 24 0 comments

Shifting the goalposts in obesity drug development

Nature Medicine, Published online: 23 June 2026; doi:10.1038/s41591-026-04462-y

Obesity drug development must move beyond an emphasis on ever-greater weight loss to prioritize tolerability, sustainable benefits and medication persistence; two recent trials exemplify this shift, with more underway.

AiNewsBlog

Leave a Comment Cancel Reply

Name	Price	7d %	Volume
Bitcoin btc	$62,636	-4.33%	$24,131,579,836
Ethereum eth	$1,667	-6.56%	$7,630,617,173
XRP xrp	$1.10	-8.28%	$1,265,010,062
Solana sol	$69	-5.12%	$1,820,238,084
Dogecoin doge	$0.079	-9.11%	$480,220,511

At Srivax, we believe in delivering fast, accurate, and relevant news to empower, inform, and engage our readers across the globe. We are an independent digital news platform built for the modern world — where information moves fast, and truth matters.